Member Info for Kong1

So today we have our update, unfortunately it corresponded with further news of another vaccine that someone has made.
Hence the price crash, Proving more people believe this share to be a covid share rather than a cancer share.

I`ve been looking through a lot of peoples posts, all commenting on BAMS and LFT etc. Yep all seems good and I still believe there is some money to be made if we can get these tests through clinical trial.
The RNS clearly states that the test has scored better than the 300 pg/ml that the test rules stipulate, So all being well we will have the highest achieving test on the market which should propel us to the front of anyone who still requires a test.
I personnally dont this it will be ready before janurary though.

One interesting sentance that no one seems to have picked up on is :-

The diagnostic business unit has also made good progress on a number of other non-COVID-19 commercial opportunities and on putting in place an ISO13485 accredited quality system to support the future growth.

So what are the other non covid commercial opportunities ? clearly something has come out of this pandemic test that isnt covid related, which however small could be another potential revenue source, May be a better pregnancy test ?
who cares as long as its another money maker,
There may be more doors that this has opened for us so hopefully the next RNS may tell us a little more.

Cancer trials starting in early 2021, for me thats FEB/MARCH results wont be till june I would say, so its slowly slowly catch the monkey.
This share isnt a smash & grab share anymore, its a long term big reward for the stayers

Considering we have a pandemic on our hands I’m really surprised at the length of time this is taking. And this is my point. We along with others are trying to produce a test that says an individual has got the COVID, and yet we have 2 or 3 companies that say they have a proven vaccine.
For me the test should be easier to complete than a vaccine and I’m really not sure I want injecting with something that has only just been made. Not enough time for me to find any side affects.
The **** really will hit the fire if things go wrong in a year or two.
So on to my next point.
I’m sure AL & Co have done all they can to produce a test kit.
I would have thought the kit has gone back and forth a number of times to fine tune it. I’m just hoping they have done that by now. But I am surprised it is taking so long considering the worlds situation.

Hurst
When a director buys or sells shares. There can be no news within 14 days of his purchase or sale.
At the moment Avacta is still in the governments hands otherwise the moment it isn’t news will have to be announced immediately.
I don’t think AS can announce anything as it’s up to the government’s body to decide whether we have a test or not.
Once a decision is made one way or the other, AS will announce accordingly.

Do we know the dividend date yet

There are high expectations for Pfizer and BioNTech to win with their Covid-19 vaccine following the latest trial update which triggered a global stock market rally and installed hope in people around the world.

The two companies will collate data until the third week of November before submitting to the regulators for approval. Safety is very important given the scale of deployment with potentially billions of perfectly healthy people being given the vaccine.

Assuming more data confirms the 90% effectiveness of the vaccine there are other considerations as more news arrives over the coming weeks.

The first big question is for how long the vaccine will provide immunity because there is no guarantee that vaccine-induced immunity will be any better than that afforded by infection.

Second, the science behind this vaccine is known as mRNA and it has never been commercialised which means no one knows for sure how to manufacture it at scale. The technology involves injecting a blueprint of the vaccine into the cells of the body so that they can make copies of the vaccine.

The vaccine needs a cold storage supply-chain because it has to be stored at minus 80 degrees centigrade. The lack of available cold refrigeration infrastructure, especially in poorer areas of the globe, may hinder distribution of the vaccine.

According to Shore Capital it is unclear at this point whether the study included patients with severe symptoms which is very important because if it didn’t it would mean the vaccine can so far only make mild cases more mild and not prevent hospitalisations.

Pfizer has targeted production of around 50 million doses for 2020 and 1.3 billion next year. Various countries have already secured agreements with Pfizer including the UK with 30 million doses. Shore Capital points out that because two doses are required and assuming wastage this would only cover around 12 million patients. It takes 28 days from the first injection to attain immunity.

The broker notes that the world will need more than one vaccine because a range of sub-groups are likely to respond differently to vaccines. Mark Brewer, analyst at FinnCap, argues that global herd immunity requires 60% to 70% of the population to become immune which given the huge numbers involved could take years to achieve.

In short, don’t expect the economy to open up quickly even if a vaccine is approved.

Two late-stage trials with results expected in the next few weeks are University of Oxford’s and AstraZeneca’s (AZN) study of compound AZD1222 and Moderna’s vaccine candidate mRNA-1273.

Both these studies include patients with severe Covid-19 symptoms and so a positive result may be more meaningful in terms of reducing hospitalisations.

Merchant banker Avacta are scientists, not manufactures, they no nothing about machines and manufacturing. It would take months to buy a premises and get it ready to accept machines, then you need to find out what the pitfalls are in manufacturing, that only comes with experience.
It would take a year or two from start to finish, then we have tried already to get this lateral flow test as quick as **** to the market and it looks like we have failed to do it quick enough. So it would still be 12-18 months away from now if we’d tried to manufacture ourselves.
It simply wouldn’t be quick enough nor cost effective enough to achieve.

For Abingdon to raise money on the potential of the AVACATA test, First they must be able to prove to investers that the test will pass all validation.
Secondly, they must be able to provide proof that the goverments of this world will still need the tests, even thou it looks like a vaccine is out.
no investor is going to take options if this is all a dead duck.
so it will be very interesting to see what they have to say. And whatever they say, AVACTA will have to make an anouncement to coincide with any info that ABINGDON MAY RELEASE !!

This last few days, much selling and not many big buys, Now all of a sudden, several really big buys, Has something been leaked ?
someone has some big balls to put that much down without knowing something, I`m smelling something here. Got a feeling a rise coming tommorrow

I keep hearing we are the best and the world still needs out test, but if it ain’t ready we can’t sell the damm thing .
I think AL was a little to optimistic with his thoughts on when it would be ready.
Personally I’m not over enthusiastic of taking a hurriedly put together vaccine, but there will be a lot of people that is.
I think we’ve missed the boat by about 2 months.
Not quite sure when or if the test will be available or how much demand there will be for it now that Pzifer have made a vaccine.
This has been a painful week, we have been seriously wounded and think the value in the company now is down to the cancer treatments

having read the last trading statement again, my concern why have a capital markets day unless your wanting more investment in the company, which means a dilution !
secondly do we know of a dividend date yet ?

Kong

Many thanks Chiron, eagle eyed as always

Having just watched the news on the testing, I noticed two types of test, one was back of throat and up the nose which wasn`t ours, but i did notice a pregnancy type test that the reporter did say was a LFT. So was that ours ?
The next question i`d like to ask some of the more knowledgeable on here. It did say only 50% accurate so which test were they on about ?

thank you very much for that Oftinhope, its the share options I wasn`t aware of then.

many thanks

i`m not sure if i`m missing something, no doubt someone will let me know.

But one or two on here, are stating Al has only sold about 4% of his holdings, yet before the sale he had 679,643, and now after the sale he only has 431,100.
not sure of the correct percentage he sold but must be around 35-40% of his holdings.

so where does the 4% come from, ? as he must have millions of shares if hes only sold 4%

We have not got a vaccine for the common cold, nor the flu.
So what makes anyone think we will get one soon for this

The government is taking "every possible step" towards creating a coronavirus vaccine, the PM says.

He adds that the UK is now testing more people than any other country in Europe, but it's vital to catch more asymptomatic cases to restrict the virus's "vicious spread".

Scientists have developed faster, cheaper tests, Boris Johnson says, and it's "becoming clear" that some of these are "highly effective".

Over the next few weeks some of these will be trialed, the PM says. Testing more quickly can prevent the spread of the virus through care homes, he adds

The BBC text had Boris saying the fast test still needs time to perfect

Hi synx

I hope you’re right.
Let’s see what the next trading statement comes up with

Crank001
rather me say anything, lets wait till next trading statement which souldn`t be long.
Tinypie, I hope your right.
The next trading statement and shareprice after will be a good indicator.
Aston is a luxury brand that will suffer in this pandemic just like all the luxury car makers

Tinypie

I don`t own a single share in the company, I don`t want them to go bankrupt, but only fools don`t consider every angle.